Overview

Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
Phase IV, observational, post-authorization, cross sectional, open-label, multicenter study to evaluate the acceptability of oral solution of levetiracetam in patients with partial epilepsy as assessed by a questionnaire.
Details
Lead Sponsor:
UCB Pharma
Treatments:
Etiracetam
Levetiracetam
Pharmaceutical Solutions
Piracetam